910 related articles for article (PubMed ID: 15638034)
1. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid and cardiovascular disorders].
Zyśko D; Gajek J
Pol Merkur Lekarski; 2004 May; 16(95):411-4. PubMed ID: 15518416
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
4. Thyrotoxicosis and the cardiovascular system.
Roffi M; Cattaneo F; Brandle M
Minerva Endocrinol; 2005 Jun; 30(2):47-58. PubMed ID: 15988401
[TBL] [Abstract][Full Text] [Related]
5. [The effects of amiodaron on the thyroid function].
Kucharczyk P; Michałkiewicz D; Kucharczyk A
Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
[TBL] [Abstract][Full Text] [Related]
6. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
Gómez JJ; Pomar MD; Casariego AV; Rodríguez IC
Endocrinol Nutr; 2009 Oct; 56(8):418-21. PubMed ID: 19959152
[TBL] [Abstract][Full Text] [Related]
7. Determinants and outcome of amiodarone-associated thyroid dysfunction.
Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyroid dysfunction in clinical practice.
Ursella S; Testa A; Mazzone M; Gentiloni Silveri N
Eur Rev Med Pharmacol Sci; 2006; 10(5):269-78. PubMed ID: 17121321
[TBL] [Abstract][Full Text] [Related]
9. Treatment of amiodarone-associated thyrotoxicosis.
Franklyn JA; Gammage MD
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Biondi B
Eur J Endocrinol; 2012 Nov; 167(5):609-18. PubMed ID: 22956554
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
13. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
Sandhu RS; Davies PH
Adverse Drug React Toxicol Rev; 2001 Jun; 20(2):105-16. PubMed ID: 11481999
[No Abstract] [Full Text] [Related]
15. [Amiodarone and thyroid disorders--prospective study and review of the literature].
Vandergheynst F; Liénart F; Ducobu J
Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone and the heart.
Moolman JA
Cardiovasc J S Afr; 2002; 13(4):159-63. PubMed ID: 12389056
[TBL] [Abstract][Full Text] [Related]
17. [Hyperthyroidism and heart].
Weissel M
Wien Klin Wochenschr; 2001 Mar; 113(5-6):157-61. PubMed ID: 11293943
[TBL] [Abstract][Full Text] [Related]
18. [Amiodarone-induced thyroid gland dysfunctions].
Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
[TBL] [Abstract][Full Text] [Related]
19. [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Serdiuk SE; Bakalov SA; Golitsyn SP; Molashenko NV; Platonova NM; Sviridenko NIu
Ter Arkh; 2005; 77(10):33-9. PubMed ID: 16320682
[TBL] [Abstract][Full Text] [Related]
20. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
